Insider Transactions in Q2 2021 at Vanda Pharmaceuticals Inc. (VNDA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
Stephen Ray Mitchell |
SELL
Open market or private sale
|
Direct |
5,000
-35.17%
|
$95,000
$19.42 P/Share
|
|
Jun 15
2021
|
Stephen Ray Mitchell |
BUY
Exercise of conversion of derivative security
|
Direct |
4,015
+22.02%
|
$40,150
$10.57 P/Share
|
|
Jun 14
2021
|
Phaedra Chrousos |
SELL
Open market or private sale
|
Direct |
2,075
-13.83%
|
$39,425
$19.34 P/Share
|
|
Jun 10
2021
|
Phaedra Chrousos |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+25.0%
|
-
|
|
Jun 10
2021
|
Richard W Dugan |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+7.71%
|
-
|
|
Jun 10
2021
|
Stephen Ray Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+32.89%
|
-
|
|
Jun 10
2021
|
Anne Sempowski Ward |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+33.33%
|
-
|
|
Jun 10
2021
|
Thomas Watkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.4%
|
-
|